Pharmaceutical Technology

MAY 18, 2023

The European Medicines Agency (EMA) has published recommendations to increase communication and planning efforts in a bid stop the current medicine shortages becoming even worse. The EMA set up a task force in 2016 in light of issues concerning medicine availability and supply chain.

Medicine 99

Medicine Specialization Networking Patients 99

European Pharmaceutical Review

APRIL 18, 2023

billion and another 200 new jobs is planned for Eli Lilly and Company’s two new pharmaceutical manufacturing sites in Boone County, US. Eli Lilly’s investment here is the largest manufacturing investment at a single location in its history. These positions will use advanced technology to help create innovative medicines.

Manufacturing 98

Manufacturing Pharmaceutical manufacturing Pharmaceutical Medicine 98

European Pharmaceutical Review

MAY 10, 2023

Sandoz has announced it is investing €25 million in its manufacturing site in Holzkirchen, Germany, to expand its biosimilar development capabilities. In April 2023, the European Commission (EC) approved the Sandoz biosimilar Hyrimoz ® (adalimumab) high-concentration (HCF) formulation for all indications of the reference medicine Humira ®.

Manufacturing 98

Manufacturing Medicine Networking Biopharma 98

European Pharmaceutical Review

FEBRUARY 7, 2024

AstraZeneca has announced a $300 million investment in a US-based manufacturing facility in Rockville, Maryland, which will focus initially on T-cell therapies for oncology indications. Currently, AstraZeneca’s manufacturing sites in the US focus on producing small molecules and biologics, the company highlighted.

Manufacturing 103

Manufacturing Medicine Networking Patients 103

European Pharmaceutical Review

NOVEMBER 20, 2023

billion parenteral (injectable) manufacturing site in Alzey, Rhineland-Palatinate, Germany. This includes automation and high-speed manufacturing lines. With the planned additional manufacturing facility in Alzey, the company will operate a total of six manufacturing sites in Europe.

Manufacturing 98

Manufacturing Medicine Biopharma Engineering 98

European Pharmaceutical Review

FEBRUARY 27, 2024

It is the company ’s most advanced manufacturing facility to date. The new facility, known as Amgen Ohio, “was designed with the latest innovation and technology to deliver safe, reliable medicines for ‘every patient, every time,'” stated Robert Bradway, Chairman and Chief Executive Officer at Amgen.

Manufacturing 105

Manufacturing Food and Drug Administration Food Networking 105

European Pharmaceutical Review

MARCH 23, 2023

Through its investment of approximately £600 million, Takeda plans to build a new manufacturing facility for plasma-derived therapies (PDTs) in Osaka, Japan. This is Takeda’s largest ever investment in manufacturing capacity expansion and will be the largest facility of its kind in Japan.

Manufacturing 89

Manufacturing Networking Medicine Medical 89

European Pharmaceutical Review

DECEMBER 30, 2024

It is estimated that only 4,000 doses of chimeric antigen receptor T cell (CAR-T) were manufactured in 2021, despite an eligible patient population of 450,000. 1 It is estimated that only 4,000 doses of chimeric antigen receptor T cell (CAR-T) were manufactured in 2021, despite an eligible patient population of 450,000.

Manufacturing 52

Manufacturing Food and Drug Administration Medicine Training 52

European Pharmaceutical Review

OCTOBER 31, 2024

It pledges to benefit key industry sectors across life sciences including R&D, innovation, manufacturing and medicine. Over the last five years Made Smarter has transformed countless SME manufacturers,” stated Donna Edwards, Director of Made Smarter’s North West adoption programme.

Manufacturing 52

Manufacturing Medical science Medicine Engineering 52

European Pharmaceutical Review

FEBRUARY 20, 2025

New analysis from Teva Pharmaceuticals Europe has reported concerning statistics regarding the security of critical medicines supply in the region is at risk. For instance, in the EU, 46 percent of generic medicines from the EU Critical List of Medicines are provided by a single supplier.

Medicine 59

Medicine Manufacturing Marketing Healthcare 59

pharmaphorum

FEBRUARY 28, 2024

Ginkgo Bioworks builds its drug discovery toolkit again, making three acquisitions and launching a partner network in AI, genetic medicines, manufacturing and other areas

Networking 76

Networking Manufacturing Medicine 76

European Pharmaceutical Review

OCTOBER 5, 2023

With 20 years of leadership experience in the life sciences and biopharma sector, Pedersen has previously had senior leadership positions in quality assurance (QA) and quality control ( QC ), regulatory affairs as well as external manufacturing. There, she oversaw the entire CDMO network.

Recruitment 105

Recruitment Manufacturing Biopharma Leads 105

European Pharmaceutical Review

DECEMBER 7, 2023

A report from the Advanced Therapies Treatment Centre (ATTC) Network has highlighted urgent need for rapid change and improvement in the field to maximise patient access to advanced therapies. It was compiled based on expertise gathered at the ATTC Network’s UK Advanced Therapies Adoption Challenge event in October.

Networking 98

Networking Medicine Leads Manufacturing 98

European Pharmaceutical Review

DECEMBER 5, 2024

Through a new agreement, Eli Lilly and Company and contract development and manufacturing organisation (CDMO) Cambrex will enable external biotech collaborators to accelerate their product development. Collaborators can also access additional support will be provided by Cambrex’s network.

Manufacturing 52

Manufacturing Pharmaceutical products Networking Pharmaceutical 52

pharmaphorum

OCTOBER 12, 2022

By remaining compliant, medicines are manufactured in line with their pre-defined and approved specifications, in order to ensure the delivery of safe and effective products to consumers. So, with mandates in place, how do manufacturing facilities meet these compliance goals? The dominion of data.

Manufacturing 105

Manufacturing Medicine Leads Distribution 105

European Pharmaceutical Review

JULY 25, 2022

As the world now looks to a post-pandemic future, despite the counterfeit medicine trade showing no signs of slowing, industry bodies must come together to tackle the production and trade of fake products. There is also the challenge of falsified medicines – the fake, unauthorised medical products that make their way into the market.

Pharmaceutical 104

Pharmaceutical Medicine Manufacturing Pharmaceutical manufacturing 104

Pharmaceutical Technology

JUNE 29, 2022

For hundreds of years, we have found myriad uses for microbial enzymes in manufacturing – from food, drink, and household products to a range of industrial applications. The next wave of medicine is well on course to be cell and gene-based. Meanwhile, the pharma industry is undergoing somewhat of a transformation itself.

Specialization 118

Specialization Biopharma B2B Sales Manufacturing 118

European Pharmaceutical Review

AUGUST 1, 2022

ViiV Healthcare and the Medicines Patent Pool (MPP) have signed a new voluntary licensing agreement to increase access to cabotegravir long-acting (LA) for HIV pre-exposure prophylaxis (PrEP) in least developed, low-income, lower middle-income and Sub-Saharan African countries.

Manufacturing 98

Manufacturing Medicine Healthcare Healthcare 98

European Pharmaceutical Review

SEPTEMBER 15, 2023

The shortlisted finalists of the CPHI awards for 2023 include companies that led by example in sustainable manufacturing, manufacturers and innovators that developed new technologies to advance drug discovery, development and manufacturing.

Pharma 119

Pharma Manufacturing Biopharma Pharmaceutical 119

pharmaphorum

OCTOBER 14, 2022

In this article, Research Partnership reviews why the path to commercialisation for the half a dozen approvals in Europe over the last few years has not been smooth, and shares feedback gathered from our payer network on the outlook for gene therapy market access in Europe, especially considering the shift to more prevalent diseases.

Medicine 93

Medicine Marketing Networking Manufacturing 93

European Pharmaceutical Review

NOVEMBER 8, 2022

Sandoz , a leading antibiotics producer has announced its €50 million investment to increase Europe’s manufacturing capacity of finished dosage form (FDF) penicillin, the most common form of antibiotic worldwide, to enhance global manufacturing capacity of amoxicillin and other major penicillin products.

Manufacturing 52

Manufacturing Networking Pharmaceutical Medicine 52

Pharmaceutical Technology

JANUARY 20, 2023

And delays in the supply chain, even for short periods of time can potentially affect the efficacy of medicines, lead to longer-term supply bottlenecks, and ultimately prevent people from getting access to the critical medicines they need. Pharma manufacturing can also be affected by extreme weather events, such as storms.

Pharma 142

Pharma Pharmaceutical Manufacturing Distribution 142

Impetus Digital

AUGUST 2, 2024

Personalized Medicine AI can help develop precision medicine by analyzing patient data , including demographic, clinical, and genetic information, as well as information about their metabolism and microbes, environmental exposures, and lifestyle factors, to predict how different patients will respond to various therapies.

Pharma 92

Pharma Manufacturing Medicine Marketing 92

European Pharmaceutical Review

OCTOBER 2, 2023

Uniting the global supply chain CPHI Barcelona serves as a vital platform for unrivalled networks and access to the global supply chain. The market space offers various benefits, including promotion as a show feature, access to start-up mentors, and a dedicated start-up networking lounge. Manufacturing Excellence 5.

Manufacturing 105

Manufacturing Pharma Networking Engineering 105

European Pharmaceutical Review

APRIL 4, 2024

The scheme aims to support UK advanced therapy medicinal product (ATMP) clinical trials. Specifically, an additional four years of funding for the Advanced Therapy Treatment Centre (ATTC) Network is available through the programme. What key solutions will the investment in the Advanced Therapy Treatment Centre Network provide?

Networking 98

Networking Training Recruitment Healthcare 98

Pharmaceutical Technology

MARCH 10, 2023

Cell One Partners has announced a strategic collaboration with the Center for Breakthrough Medicines (CBM) to expedite the development and commercialisation of cell and gene therapies. Cell One Partners offers virtual company creation and management to its clients for complete aspects of the development and commercialisation of drugs.

Manufacturing 98

Manufacturing Management Medicine Networking 98

European Pharmaceutical Review

JUNE 24, 2022

Located in Kigali, Rwanda, the mRNA manufacturing facility will be the first of three planned sites across the continent, with further factories to come in Senegal and South Africa. Together this network of factories will supply therapies and vaccines solely for people residing in member states of the African Union.

Manufacturing 96

Manufacturing Training Networking Medicine 96

pharmaphorum

JANUARY 27, 2023

It is being supported by several patient advocacy groups, including the AIDS Institute, the National Oncology State Network, and the HIV + Hepatitis Policy Institute. The case is Johnson & Johnson Healthcare Systems v. Save On SP, LLC, 2:22-cv-02632, being heard in the US District Curt for the District of New Jersey.

Insurance 105

Insurance Medicine Patients Prescription 105

European Pharmaceutical Review

AUGUST 31, 2023

Overcoming challenges in patient safety, manufacturing and supply of radiopharmaceuticals As clinical trials progress and the first results are published, companies’ best candidates will emerge in the next five years. Long production times and high energy costs in manufacturing are additional considerations.

Food and Drug Administration 97

Food and Drug Administration Manufacturing Safety Transportation 97

European Pharmaceutical Review

SEPTEMBER 15, 2022

The investment is part of the company’s global effort to implement the most innovative technologies and most sustainable processes at its manufacturing sites. Dr Thomas Wozniewski, Global Manufacturing and Supply Officer, added: “For 50 years, this site has been transforming human plasma into life-saving and life-sustaining medicines.

Manufacturing 98

Manufacturing Training Patients Networking 98

Pharmaceutical Technology

JANUARY 26, 2023

“With cell and gene therapy, not only does it offer the management of symptoms like other conventional medicines, but it also offers the potential of a cure. RoslinCT began as a spin-out from the Roslin Institute – now part of the University of Edinburgh – in 2006, providing expertise in regenerative medicine.

Medicine 52

Medicine Manufacturing Medical Marketing 52

European Pharmaceutical Review

DECEMBER 22, 2022

A pharmaceutical tablet is a 3D sample that comprises a mixture of components in which some are arranged as a network of agglomerated particles. Therefore, 2D imaging and mapping approaches may not provide a true representation of these networks throughout a tablet matrix.

Pharmaceutical 98

Pharmaceutical Distribution Networking Pharmaceutical products 98

European Pharmaceutical Review

APRIL 2, 2024

For companies that manufacture globally marketed products, the journey towards implementing rFC is a slow one” There are two possibilities for rFC implementation, depending on the pharmacopeial guidance. However, for companies that manufacture globally marketed products, the journey towards implementing rFC is a slow one.

Manufacturing 98

Manufacturing Ethics Marketing Networking 98

Pharmaceutical Technology

JUNE 5, 2023

Rezvilutamide is under clinical development by Jiangsu Hengrui Medicine and currently in Phase III for Prostate Cancer. Jiangsu Hengrui Medicine overview Jiangsu Hengrui Medicine (Jiangsu Hengrui) is a biopharmaceutical company that focuses on the research, development, manufacture, and distribution of novel pharmaceutical products.

Medicine 40

Medicine Distribution Pharmaceutical products Networking 40

European Pharmaceutical Review

MARCH 15, 2023

MZmine also supports IMS-MS addressing the introduction of more IMS-enabled instruments by multiple instrument manufacturers Free to use – an MIT license means MZmine is open-source and free for commercial and non-commercial use, facilitating optimal collaboration.

Distribution 139

Distribution Networking Manufacturing Medicine 139

European Pharmaceutical Review

APRIL 4, 2024

US radiopharmacy network RLS Radiopharmacies is expanding its radiopharmaceutical contract development and manufacturing (rCDMO) capabilities by establishing a partnership with global isotope technology company Eckert & Ziegler.

Transportation 98

Transportation Distribution Management Healthcare 98

Pharmaceutical Technology

JUNE 5, 2023

Rezvilutamide is under clinical development by Jiangsu Hengrui Medicine and currently in Phase I for Liver Failure (Hepatic Insufficiency). The company offers products through its sales and distribution network in China, the US, Japan, Germany Switzerland, and Australia.

Medicine 40

Medicine Distribution Pharmaceutical products Networking 40